That's a fantastic question. I know we're short on time, so I'm going to say, yes, I would recommend that we have a longitudinal study or a clinical trial—depending on how it's done—that looks at the impact on women of environmental factors, racism, the social determinants of health and trauma. The epigenetics study I referred to in the U.S. was actually based on a longitudinal study looking at women who developed chronic disease in their forties. The only evidence or factor that correlated with the development of a chronic disease in their forties was having a trauma, and that was irrespective of ethnicity.
To your point about younger white women having breast cancer at a young age, it was definitely linked to trauma before the age of 10. If a woman experienced any kind of trauma before the age of 10, whether it was the loss of a family member or parent, being in a car accident or anything incredibly traumatic, it correlated with the epigenetic changes that were seen on their genome and with having a chronic disease in their forties, whether it be diabetes, cardiovascular disease or cancer.
I would therefore recommend that we engage and look at the data coming out of the U.S., where they're doing these studies. We don't have to reinvent the wheel. We can use some of that data in our Canadian context and do it faster and better.